Primary |
Drug Use For Unknown Indication |
51.0% |
Product Used For Unknown Indication |
31.5% |
Dementia Alzheimer's Type |
3.8% |
Ill-defined Disorder |
3.4% |
Hypertension |
1.7% |
Constipation |
1.4% |
Drug Exposure During Pregnancy |
1.4% |
Depression |
1.0% |
Nonspecific Reaction |
1.0% |
Schizophrenia, Paranoid Type |
1.0% |
Korsakoff's Psychosis Non-alcoholic |
0.7% |
Mental Disorder |
0.7% |
Pain |
0.7% |
Blood Glucose Abnormal |
0.3% |
Schizophrenia |
0.3% |
|
Suicide Attempt |
20.8% |
Somnolence |
16.7% |
Vomiting |
10.4% |
Tachycardia |
8.3% |
Death |
4.2% |
Fall |
4.2% |
Hyponatraemia |
4.2% |
Hypotension |
4.2% |
Wrong Drug Administered |
4.2% |
Arrhythmia |
2.1% |
Blood Pressure Decreased |
2.1% |
Disturbance In Attention |
2.1% |
Drug Interaction |
2.1% |
Dyspnoea |
2.1% |
Fatigue |
2.1% |
Hepatitis Acute |
2.1% |
Pancreatitis Necrotising |
2.1% |
Parkinsonism |
2.1% |
Psychotic Disorder |
2.1% |
Salivary Hypersecretion |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
32.0% |
Drug Use For Unknown Indication |
30.2% |
Depression |
6.7% |
Dementia Alzheimer's Type |
3.9% |
Sleep Disorder |
3.0% |
Hypertension |
2.5% |
Restlessness |
2.4% |
Ill-defined Disorder |
2.3% |
Psychotic Disorder |
2.3% |
Schizophrenia, Paranoid Type |
2.2% |
Aggression |
1.6% |
Cerebrovascular Accident |
1.6% |
Constipation |
1.6% |
Circadian Rhythm Sleep Disorder |
1.4% |
Agitation |
1.2% |
Epilepsy |
1.2% |
Schizophrenia |
1.2% |
Pain |
1.1% |
Prophylaxis Of Neural Tube Defect |
0.9% |
Bipolar Disorder |
0.8% |
|
Fall |
13.1% |
Somnolence |
11.0% |
Spina Bifida |
8.3% |
Pleurothotonus |
6.9% |
Respiratory Failure |
6.2% |
Suicide Attempt |
5.5% |
Tachycardia |
4.8% |
Thrombocytopenia |
4.8% |
Death |
4.1% |
Patent Ductus Arteriosus |
4.1% |
Agranulocytosis |
3.4% |
Aphthous Stomatitis |
3.4% |
Delirium |
3.4% |
Hyponatraemia |
3.4% |
Urinary Retention |
3.4% |
Dermatitis Allergic |
2.8% |
Parkinsonism |
2.8% |
Premature Baby |
2.8% |
Syncope |
2.8% |
Thrombosis |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
25.9% |
Drug Use For Unknown Indication |
17.5% |
Hypertension |
9.4% |
Depression |
7.4% |
Sleep Disorder |
4.4% |
Schizophrenia |
3.9% |
Epilepsy |
3.4% |
Pain |
3.2% |
Restlessness |
2.7% |
Rheumatoid Arthritis |
2.7% |
Agitation |
2.5% |
Back Pain |
2.5% |
Psychotic Disorder |
2.4% |
Thrombosis Prophylaxis |
2.2% |
Diabetes Mellitus |
2.0% |
Schizoaffective Disorder |
2.0% |
Chronic Infantile Neurological Cutaneous And Articular Syndrome |
1.8% |
Hypokalaemia |
1.5% |
Hypopharyngeal Cancer |
1.3% |
Pruritus |
1.3% |
|
Neutropenia |
9.8% |
Off Label Use |
8.7% |
Faecaloma |
7.6% |
Drug Interaction |
6.5% |
Tibia Fracture |
6.5% |
Vomiting |
6.5% |
Renal Failure Acute |
5.4% |
Ejaculation Disorder |
4.3% |
Nausea |
4.3% |
Overdose |
4.3% |
Psychomotor Hyperactivity |
4.3% |
Sedation |
4.3% |
Syncope |
4.3% |
Aggression |
3.3% |
Insomnia |
3.3% |
Pneumonia |
3.3% |
Salivary Hypersecretion |
3.3% |
Schizophrenia |
3.3% |
Sleep Disorder |
3.3% |
Toxic Epidermal Necrolysis |
3.3% |
|
Interacting |
Drug Use For Unknown Indication |
25.5% |
Asthenia |
11.4% |
Initial Insomnia |
11.4% |
Middle Insomnia |
11.4% |
Back Pain |
6.0% |
Cardiac Failure |
4.0% |
Cerebrovascular Accident |
4.0% |
Epilepsy |
4.0% |
Product Used For Unknown Indication |
4.0% |
Anxiety Disorder |
2.0% |
Benign Prostatic Hyperplasia |
2.0% |
Constipation |
2.0% |
Metabolic Syndrome |
2.0% |
Muscle Spasticity |
2.0% |
Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
Renal Impairment |
2.0% |
Type 2 Diabetes Mellitus |
2.0% |
Agitation |
0.7% |
Dementia Alzheimer's Type |
0.7% |
Depression |
0.7% |
|
Hyperhidrosis |
58.6% |
Sleep Apnoea Syndrome |
10.3% |
Somnolence |
10.3% |
Drug Interaction |
3.4% |
Leukopenia |
3.4% |
Respiratory Failure |
3.4% |
Restlessness |
3.4% |
Thrombocytopenia |
3.4% |
Troponin Increased |
3.4% |
|